cannabinoid Archives - TheJointBlog

Kansas Bill Legalizing Cannabinoid Medicines Passes Senate Committee

March 10, 2017 by Anthony Martinelli

A Kansas Senate committee has passed a bill to legalize cannabinoid (CBD) medicines.

Senate Bill 151 was approved Thursday by the Senate Federal and State Affairs Committee, moving it towards a full Senate vote. Under the proposed law; “a person shall not be subject to arrest, prosecution or penalty in any manner for possessing, utilizing, dispensing or distributing any non-intoxicating cannabinoid medicine or any apparatus or paraphernalia used to administer such medicine pursuant to a physician recommendation.”

The proposal makes it clear that; ‘a physician shall not be subject to arrest, prosecution or penalty in any manner, including any form of professional discipline by the state board of healing arts, for issuing a recommendation order, with the same intent, force and effect as a prescription order, to a patient for the use of non-intoxicating cannabinoid medicine.”

Study: Cannabis May Protect Against Colitis

February 24, 2015 by Anthony Martinelli

A new study published in the journal ACS Medicinal Chemistry Letters has found that activation of the cannabinoid receptors – something done naturally by cannabis – can protect against colitis, which is an inflammatory reaction in the colon that is often autoimmune or infectious.

According to the study; “The CB2 cannabinoid receptor has been implicated in the regulation of intestinal inflammation”. With this in mind, researchers “developed constrained analogues” that were specifically designed to target the body’s cannabinoid receptors.

New Study Finds Cannabis May Help Combat Osteoporosis in Men With Prostate Disease

August 23, 2014August 23, 2014 by Anthony Martinelli

A new study has found evidence that cannabis may help treat osteoporosis, specifically in men suffering from prostate disease.

According to researchers from Konkuk University, in Seoul, Republic of Korea, a substantial portion of men with prostatic disease have an increased risk of bone loss, but activating cannabinoid receptors can help combat these effects. Scientists induced prostatic hyperplasia (enlargement of the prostate gland) in rats and administered a cannabinoid agonist. The enhanced cannabinoid receptor expression caused an upregulation of osteoblastogenesis, or an increase in bone growth, while inhibiting the prostatic hyperplasia.

New Study Concludes Cannabis Increases Appetite by Enhancing Sense of Smell

July 31, 2015February 11, 2014 by Anthony Martinelli

A new study published this week in the journal Nature Neuroscience has revealed why cannabis can act as an appetite stimulant.

A group of European scientists examined the standard smelling and eating patterns of mice, and compared them to patterns exhibited by mice given THC.

Both groups of mice were offered almond and banana oils; while the mice in the control group sniffed the oils and eventually lost interest, the group of mice who were administered THC just kept sniffing. When offered food, the mice who were given THC ate substantially more than the control group.

New Study: Cannabinoids Can Kill Gastric Cancers Cells

December 29, 2013December 19, 2013 by Anthony Martinelli

A new study published in the journal Chemotherapy has found that cannabinoid receptor activation – something done naturally by cannabis and cannabinoids – can lead to the death of gastric cancer cells.

For the study, researchers at the Catholic University of Korea’s Department of Internal Medicine studied the effects of a cannabinoid receptor agonist (which cannabis is) on mice injected with gastric cancer cells.

BREAKING: FDA Approves Trials for Cannabis-Based Epilepsy Medicine

October 24, 2013October 22, 2013 by Anthony Martinelli

The U.S. Federal Drug Administration has given unprecedented approval for two separate trials of Epidiolex, a liquid medicine made entirely of cannabis; the substance contains 98% cannabidiol, a nonpsychoactive compound found in cannabis – the remaining 2% consist of various trace amounts of other cannabinoids.

The studies will be led by Orrin Devinsky, MD at New York University’s School of Medicine, and Roberta Cilio, MD, PhD, at the University of California.

Each study will involve 25 participants, all children.

New Study: Cannabis May Treat Addiction

December 1, 2013October 2, 2013 by Anthony Martinelli

According to a new study published last week by the National Institute of Health, cannabis may be an effective treatment in curing people of addiction from hard drugs such as cocaine and amphetamines.

According to researchers, this study “presents an up-to-date review with deep insights into the pivotal role of the ECBS [endocannabinod system] in the neurobiology of stimulant addiction and the effects of its modulation on addictive behaviors. They state that; “A growing number of studies support a critical role of the ECBS and its modulation by synthetic or natural cannabinoids in various neurobiological and behavioral aspects of stimulants addiction.”

Dysfunctional Endocannabinoid System May Lead to Eating Disorders

October 1, 2013 by Anthony Martinelli

A recent study published by the European Journal of Nuclear Medicine and Molecular Imaging as well as the National Institute of Health has found evidence to suggest that a dysfunctional endocannabinoid system may lead to eating disorders such as anorexia nervosa. These results indicate that cannabis may be an effective treatment for these types of disorders, given that it naturally activates and heals our body’s cannabinoid receptors.

Cannabis May Treat Celiac Disease, According to Recent Government-Published Study

September 30, 2013September 29, 2013 by Anthony Martinelli

A National Institute of Health study published earlier this year found that cannabis may treat celiac disease by activating the body’s natural cannabinoid receptors. Celiac disease is an autoimmune disorder of the small intestine which some people are genetically predisposed to.

The study, which was conducted by researchers at the Department of Biomedical Sciences at the University of Teramo in Italy, aimed to “investigate the expression of CBR [cannabinoid receptors] at transcriptional and translational levels in the duodenal mucosa of untreated celiac patients, celiac patients on a gluten-free diet for at least 12 months and control subjects. Also biopsies from treated celiac patients cultured ex vivo with peptic-tryptic digest of gliadin were investigated.”

University Lecturer Receives Prestigious Neuroscience Award for Work With Cannabinoids

September 27, 2013September 27, 2013 by Anthony Martinelli

Dr. Eric Downer, an investigator and lecturer at the Department of Anatomy & Neuroscience at the University College Cork in Ireland, has become the newest recipient of the prestigious Neuroscience Ireland Early Career Investigator Award for his pioneering work using cannabinoids to treat multiple sclerosis.

‘It is an important time in the field of cannabinoid-based scientific research, particularly in terms of cannabis-based therapies associated with MS’, says Dr Downer, “My research has indicated that MS patient cells, and not cells isolated from healthy individuals, respond to cannabinoid therapy in terms of boosting protective intracellular signaling events.”